Financial reports
ARS
2023 FY
Annual report to shareholders
2 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
Current reports
8-K
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
27 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
8 Jan 24
8-K
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System
13 Jun 23
8-K
Regulation FD Disclosure
1 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
8-K
Treace Medical Concepts Reports First Quarter 2023 Financial Results
8 May 23
8-K
Other Events
10 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
8 Mar 23
424B5
Prospectus supplement for primary offering
8 Feb 23
424B5
Prospectus supplement for primary offering
7 Feb 23
S-3ASR
Automatic shelf registration
7 Feb 23
S-8
Registration of securities for employees
4 Mar 22
S-8
Registration of securities for employees
27 Apr 21
424B4
Prospectus supplement with pricing info
26 Apr 21
S-1MEF
Registration of additional securities for an S-1
22 Apr 21
8-A12B
Registration of securities on exchange
20 Apr 21
S-1/A
IPO registration (amended)
19 Apr 21
Other
EFFECT
Notice of effectiveness
23 Apr 21
CERT
Certification of approval for exchange listing
22 Apr 21
CORRESP
Correspondence with SEC
20 Apr 21
CORRESP
Correspondence with SEC
20 Apr 21
CORRESP
Correspondence with SEC
19 Apr 21
UPLOAD
Letter from SEC
14 Apr 21
CORRESP
Correspondence with SEC
30 Mar 21
UPLOAD
Letter from SEC
11 Mar 21
Ownership
4
JAMES T TREACE
29 Mar 24
4
Aaron Berutti
12 Mar 24
4
Mark Hair
12 Mar 24
4
John T. Treace
12 Mar 24
4
Sean F. Scanlan
12 Mar 24
4
Scot Michael Elder
12 Mar 24
SC 13G/A
ALLIANCEBERNSTEIN L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Treace John T.
9 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24